English
Segment disclosures
Company overviewBIO-TECHNE Corp
Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.
Revenue · Reported segment facts
Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.
Changzhou Eminence Biotechnology · Protein Sciences
Consolidated Entities · Statement Business Segments
Source dimensions
srt:ConsolidatedEntitiesAxis=tech:ChangzhouEminenceBiotechnologyMember;us-gaap:StatementBusinessSegmentsAxis=tech:ProteinSciencesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-07-01 – 2022-09-30 | 2000000 | USD | 20250822 | Open filing evidence |
| 2021-07-01 – 2022-06-30 | 4600000 | USD | 20240822 | Open filing evidence |
Intersegment Elimination · All Other Segments
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:IntersegmentEliminationMember;us-gaap:StatementBusinessSegmentsAxis=us-gaap:AllOtherSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-07-01 – 2024-06-30 | 4153000 | USD | 20250822 | Open filing evidence |
Operating Segments · Consumables · Diagnostics And Genomics
Consolidation Items · Product Or Service · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=tech:ConsumablesMember;us-gaap:StatementBusinessSegmentsAxis=tech:DiagnosticsAndGenomicsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-07-01 – 2024-06-30 | 266348000 | USD | 20240822 | Open filing evidence |
| 2022-07-01 – 2023-06-30 | 252432000 | USD | 20240822 | Open filing evidence |
| 2021-07-01 – 2022-06-30 | 243922000 | USD | 20240822 | Open filing evidence |
| 2020-07-01 – 2021-06-30 | 194948000 | USD | 20230823 | Open filing evidence |
| 2019-07-01 – 2020-06-30 | 171590000 | USD | 20220824 | Open filing evidence |
Operating Segments · Consumables · Diagnostics And Spatial Biology
Consolidation Items · Product Or Service · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=tech:ConsumablesMember;us-gaap:StatementBusinessSegmentsAxis=tech:DiagnosticsAndSpatialBiologyMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-07-01 – 2026-06-30 | 304267000 | USD | 20260824 | Open filing evidence |
| 2024-07-01 – 2025-06-30 | 283969000 | USD | 20260824 | Open filing evidence |
| 2023-07-01 – 2024-06-30 | 266348000 | USD | 20260824 | Open filing evidence |
| 2022-07-01 – 2023-06-30 | 252432000 | USD | 20250822 | Open filing evidence |
Operating Segments · Consumables · Other Revenues From Business Held For Sale
Consolidation Items · Product Or Service · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=tech:ConsumablesMember;us-gaap:StatementBusinessSegmentsAxis=tech:OtherRevenuesFromBusinessHeldForSaleMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-07-01 – 2024-06-30 | 4153000 | USD | 20240822 | Open filing evidence |
Operating Segments · Consumables · Protein Sciences
Consolidation Items · Product Or Service · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=tech:ConsumablesMember;us-gaap:StatementBusinessSegmentsAxis=tech:ProteinSciencesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-07-01 – 2026-06-30 | 680848000 | USD | 20260824 | Open filing evidence |
| 2024-07-01 – 2025-06-30 | 684165000 | USD | 20260824 | Open filing evidence |
| 2023-07-01 – 2024-06-30 | 657679000 | USD | 20260824 | Open filing evidence |
| 2022-07-01 – 2023-06-30 | 665301000 | USD | 20250822 | Open filing evidence |
| 2021-07-01 – 2022-06-30 | 646952000 | USD | 20240822 | Open filing evidence |
| 2020-07-01 – 2021-06-30 | 557037000 | USD | 20230823 | Open filing evidence |
| 2019-07-01 – 2020-06-30 | 431052000 | USD | 20220824 | Open filing evidence |
Operating Segments · Consumables · All Other Segments
Consolidation Items · Product Or Service · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=tech:ConsumablesMember;us-gaap:StatementBusinessSegmentsAxis=us-gaap:AllOtherSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-07-01 – 2025-06-30 | 4152000 | USD | 20260824 | Open filing evidence |
| 2023-07-01 – 2024-06-30 | 4153000 | USD | 20260824 | Open filing evidence |
Operating Segments · Diagnostics And Genomics
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=tech:DiagnosticsAndGenomicsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-07-01 – 2024-06-30 | 326392000 | USD | 20240822 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 87511000 | USD | 20240506 | Open filing evidence |
| 2023-07-01 – 2024-03-31 | 235715000 | USD | 20240506 | Open filing evidence |
| 2023-10-01 – 2023-12-31 | 75408000 | USD | 20240207 | Open filing evidence |
| 2023-07-01 – 2023-12-31 | 148204000 | USD | 20240207 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 72797000 | USD | 20231107 | Open filing evidence |
| 2022-07-01 – 2023-06-30 | 292602000 | USD | 20240822 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 75669000 | USD | 20240506 | Open filing evidence |
| 2022-07-01 – 2023-03-31 | 213577000 | USD | 20240506 | Open filing evidence |
| 2022-10-01 – 2022-12-31 | 68003000 | USD | 20240207 | Open filing evidence |
| 2022-07-01 – 2022-12-31 | 137907000 | USD | 20240207 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 69904000 | USD | 20231107 | Open filing evidence |
| 2021-07-01 – 2022-06-30 | 274843000 | USD | 20240822 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 77679000 | USD | 20230508 | Open filing evidence |
| 2021-07-01 – 2022-03-31 | 203191000 | USD | 20230508 | Open filing evidence |
| 2021-10-01 – 2021-12-31 | 64527000 | USD | 20230207 | Open filing evidence |
| 2021-07-01 – 2021-12-31 | 125512000 | USD | 20230207 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 60985000 | USD | 20221107 | Open filing evidence |
| 2020-07-01 – 2021-06-30 | 227744000 | USD | 20230823 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 58093000 | USD | 20220509 | Open filing evidence |
| 2020-07-01 – 2021-03-31 | 160687000 | USD | 20220509 | Open filing evidence |
| 2020-10-01 – 2020-12-31 | 52469000 | USD | 20220207 | Open filing evidence |
| 2020-07-01 – 2020-12-31 | 102595000 | USD | 20220207 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 50125000 | USD | 20211108 | Open filing evidence |
| 2019-07-01 – 2020-06-30 | 184549000 | USD | 20220824 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 49411000 | USD | 20210507 | Open filing evidence |
| 2019-07-01 – 2020-03-31 | 135808000 | USD | 20210507 | Open filing evidence |
| 2019-10-01 – 2019-12-31 | 43846000 | USD | 20210208 | Open filing evidence |
| 2019-07-01 – 2019-12-31 | 86397000 | USD | 20210208 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 42552000 | USD | 20201109 | Open filing evidence |
| 2018-07-01 – 2019-06-30 | 171674000 | USD | 20210825 | Open filing evidence |
| 2019-01-01 – 2019-03-31 | 47134000 | USD | 20200511 | Open filing evidence |
| 2018-07-01 – 2019-03-31 | 123144000 | USD | 20200511 | Open filing evidence |
| 2018-10-01 – 2018-12-31 | 39263000 | USD | 20200206 | Open filing evidence |
| 2018-07-01 – 2018-12-31 | 76010000 | USD | 20200206 | Open filing evidence |
| 2018-07-01 – 2018-09-30 | 36747000 | USD | 2019-11-06 · 21:41:35.000Z | Open filing evidence |
| 2017-07-01 – 2018-06-30 | 161151000 | USD | 20200826 | Open filing evidence |
| 2018-01-01 – 2018-03-31 | 40929000 | USD | 20190507 | Open filing evidence |
| 2017-07-01 – 2018-03-31 | 114604000 | USD | 20190507 | Open filing evidence |
| 2017-10-01 – 2017-12-31 | 37086000 | USD | 20190207 | Open filing evidence |
| 2017-07-01 – 2017-12-31 | 73675000 | USD | 20190207 | Open filing evidence |
| 2017-07-01 – 2017-09-30 | 36589000 | USD | 20181107 | Open filing evidence |
| 2016-07-01 – 2017-06-30 | 143742000 | USD | 20191106 | Open filing evidence |
Operating Segments · Diagnostics And Spatial Biology
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=tech:DiagnosticsAndSpatialBiologyMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 80164000 | USD | 2026-11-12 · 21:31:23.000Z | Open filing evidence |
| 2025-07-01 – 2026-06-30 | 336365000 | USD | 20260824 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 85586000 | USD | 20260506 | Open filing evidence |
| 2025-07-01 – 2026-03-31 | 246224000 | USD | 20260506 | Open filing evidence |
| 2025-10-01 – 2025-12-31 | 81180000 | USD | 20260204 | Open filing evidence |
| 2025-07-01 – 2025-12-31 | 160638000 | USD | 20260204 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 79458000 | USD | 2026-11-12 · 21:31:23.000Z | Open filing evidence |
| 2024-07-01 – 2025-06-30 | 346263000 | USD | 20260824 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 89231000 | USD | 20260506 | Open filing evidence |
| 2024-07-01 – 2025-03-31 | 256558000 | USD | 20260506 | Open filing evidence |
| 2024-10-01 – 2024-12-31 | 84135000 | USD | 20260204 | Open filing evidence |
| 2024-07-01 – 2024-12-31 | 167327000 | USD | 20260204 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 83192000 | USD | 20251105 | Open filing evidence |
| 2023-07-01 – 2024-06-30 | 326392000 | USD | 20260824 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 87511000 | USD | 20250508 | Open filing evidence |
| 2023-07-01 – 2024-03-31 | 235715000 | USD | 20250508 | Open filing evidence |
| 2023-10-01 – 2023-12-31 | 75408000 | USD | 20250206 | Open filing evidence |
| 2023-07-01 – 2023-12-31 | 148204000 | USD | 20250206 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 72797000 | USD | 20241105 | Open filing evidence |
| 2022-07-01 – 2023-06-30 | 292602000 | USD | 20250822 | Open filing evidence |
Operating Segments · Protein Sciences
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=tech:ProteinSciencesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 219691000 | USD | 2026-11-12 · 21:31:23.000Z | Open filing evidence |
| 2025-07-01 – 2026-06-30 | 874620000 | USD | 20260824 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 226154000 | USD | 20260506 | Open filing evidence |
| 2025-07-01 – 2026-03-31 | 643426000 | USD | 20260506 | Open filing evidence |
| 2025-10-01 – 2025-12-31 | 215084000 | USD | 20260204 | Open filing evidence |
| 2025-07-01 – 2025-12-31 | 417272000 | USD | 20260204 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 202188000 | USD | 2026-11-12 · 21:31:23.000Z | Open filing evidence |
| 2024-07-01 – 2025-06-30 | 870245000 | USD | 20260824 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 227687000 | USD | 20260506 | Open filing evidence |
| 2024-07-01 – 2025-03-31 | 643774000 | USD | 20260506 | Open filing evidence |
| 2024-10-01 – 2024-12-31 | 211551000 | USD | 20260204 | Open filing evidence |
| 2024-07-01 – 2024-12-31 | 416086000 | USD | 20260204 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 204535000 | USD | 20251105 | Open filing evidence |
| 2023-07-01 – 2024-06-30 | 830902000 | USD | 20260824 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 214589000 | USD | 20250508 | Open filing evidence |
| 2023-07-01 – 2024-03-31 | 616914000 | USD | 20250508 | Open filing evidence |
| 2023-10-01 – 2023-12-31 | 197670000 | USD | 20250206 | Open filing evidence |
| 2023-07-01 – 2023-12-31 | 402325000 | USD | 20250206 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 204655000 | USD | 20241105 | Open filing evidence |
| 2022-07-01 – 2023-06-30 | 845747000 | USD | 20250822 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 218903000 | USD | 20240506 | Open filing evidence |
| 2022-07-01 – 2023-03-31 | 622739000 | USD | 20240506 | Open filing evidence |
| 2022-10-01 – 2022-12-31 | 203887000 | USD | 20240207 | Open filing evidence |
| 2022-07-01 – 2022-12-31 | 403836000 | USD | 20240207 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 199949000 | USD | 20231107 | Open filing evidence |
| 2021-07-01 – 2022-06-30 | 832311000 | USD | 20240822 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 213176000 | USD | 20230508 | Open filing evidence |
| 2021-07-01 – 2022-03-31 | 615332000 | USD | 20230508 | Open filing evidence |
| 2021-10-01 – 2021-12-31 | 204971000 | USD | 20230207 | Open filing evidence |
| 2021-07-01 – 2021-12-31 | 402156000 | USD | 20230207 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 197186000 | USD | 20221107 | Open filing evidence |
| 2020-07-01 – 2021-06-30 | 704564000 | USD | 20230823 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 185623000 | USD | 20220509 | Open filing evidence |
| 2020-07-01 – 2021-03-31 | 512248000 | USD | 20220509 | Open filing evidence |
| 2020-10-01 – 2020-12-31 | 172179000 | USD | 20220207 | Open filing evidence |
| 2020-07-01 – 2020-12-31 | 326625000 | USD | 20220207 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 154446000 | USD | 20211108 | Open filing evidence |
| 2019-07-01 – 2020-06-30 | 555352000 | USD | 20220824 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 145509000 | USD | 20210507 | Open filing evidence |
| 2019-07-01 – 2020-03-31 | 428021000 | USD | 20210507 | Open filing evidence |
| 2019-10-01 – 2019-12-31 | 141517000 | USD | 20210208 | Open filing evidence |
| 2019-07-01 – 2019-12-31 | 282512000 | USD | 20210208 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 140995000 | USD | 20201109 | Open filing evidence |
| 2018-07-01 – 2019-06-30 | 543159000 | USD | 20210825 | Open filing evidence |
| 2019-01-01 – 2019-03-31 | 137935000 | USD | 20200511 | Open filing evidence |
| 2018-07-01 – 2019-03-31 | 399787000 | USD | 20200511 | Open filing evidence |
| 2018-10-01 – 2018-12-31 | 135462000 | USD | 20200206 | Open filing evidence |
| 2018-07-01 – 2018-12-31 | 261852000 | USD | 20200206 | Open filing evidence |
| 2018-07-01 – 2018-09-30 | 126391000 | USD | 2019-11-06 · 21:41:35.000Z | Open filing evidence |
| 2017-07-01 – 2018-06-30 | 482378000 | USD | 20200826 | Open filing evidence |
| 2018-01-01 – 2018-03-31 | 123187000 | USD | 20190507 | Open filing evidence |
| 2017-07-01 – 2018-03-31 | 348442000 | USD | 20190507 | Open filing evidence |
| 2017-10-01 – 2017-12-31 | 117142000 | USD | 20190207 | Open filing evidence |
| 2017-07-01 – 2017-12-31 | 225255000 | USD | 20190207 | Open filing evidence |
| 2017-07-01 – 2017-09-30 | 108113000 | USD | 20181107 | Open filing evidence |
| 2016-07-01 – 2017-06-30 | 419365000 | USD | 20191106 | Open filing evidence |
Consumables · Diagnostics And Genomics
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=tech:ConsumablesMember;us-gaap:StatementBusinessSegmentsAxis=tech:DiagnosticsAndGenomicsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-07-01 – 2021-06-30 | 194948000 | USD | 20210825 | Open filing evidence |
| 2019-07-01 – 2020-06-30 | 171590000 | USD | 20210825 | Open filing evidence |
| 2018-07-01 – 2019-06-30 | 158324000 | USD | 20210825 | Open filing evidence |
| 2017-07-01 – 2018-06-30 | 150388000 | USD | 20200826 | Open filing evidence |
| 2016-07-01 – 2017-06-30 | 134930000 | USD | 20191106 | Open filing evidence |
Consumables · Protein Sciences
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=tech:ConsumablesMember;us-gaap:StatementBusinessSegmentsAxis=tech:ProteinSciencesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-07-01 – 2021-06-30 | 557037000 | USD | 20210825 | Open filing evidence |
| 2019-07-01 – 2020-06-30 | 431052000 | USD | 20210825 | Open filing evidence |
| 2018-07-01 – 2019-06-30 | 430655000 | USD | 20210825 | Open filing evidence |
| 2017-07-01 – 2018-06-30 | 384350000 | USD | 20200826 | Open filing evidence |
| 2016-07-01 – 2017-06-30 | 341611000 | USD | 20191106 | Open filing evidence |
Reportable Segment · Biotechnology
Consolidation Items · Statement Business Segments
Source dimensions
us-gaap:ConsolidationItemsAxis=tech:ReportableSegmentMember;us-gaap:StatementBusinessSegmentsAxis=tech:BiotechnologyMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2013-10-01 – 2013-12-31 | 70557000 | USD | 20140204 | Open filing evidence |
| 2013-07-01 – 2013-12-31 | 143747000 | USD | 20140204 | Open filing evidence |
| 2013-07-01 – 2013-09-30 | 73190000 | USD | 20131112 | Open filing evidence |
| 2012-10-01 – 2012-12-31 | 69628000 | USD | 20140204 | Open filing evidence |
| 2012-07-01 – 2012-12-31 | 139131000 | USD | 20140204 | Open filing evidence |
| 2012-07-01 – 2012-09-30 | 69503000 | USD | 20131112 | Open filing evidence |
Reportable Segment · Clinical Controls
Consolidation Items · Statement Business Segments
Source dimensions
us-gaap:ConsolidationItemsAxis=tech:ReportableSegmentMember;us-gaap:StatementBusinessSegmentsAxis=tech:ClinicalControlsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2013-10-01 – 2013-12-31 | 13460000 | USD | 20140204 | Open filing evidence |
| 2013-07-01 – 2013-12-31 | 25938000 | USD | 20140204 | Open filing evidence |
| 2013-07-01 – 2013-09-30 | 12478000 | USD | 20131112 | Open filing evidence |
| 2012-10-01 – 2012-12-31 | 5455000 | USD | 20140204 | Open filing evidence |
| 2012-07-01 – 2012-12-31 | 10977000 | USD | 20140204 | Open filing evidence |
| 2012-07-01 – 2012-09-30 | 5522000 | USD | 20131112 | Open filing evidence |
Material Reconciling Items · Biotechnology
Consolidation Items · Statement Business Segments
Source dimensions
us-gaap:ConsolidationItemsAxis=us-gaap:MaterialReconcilingItemsMember;us-gaap:StatementBusinessSegmentsAxis=tech:BiotechnologyMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2014-10-01 – 2014-12-31 | 77951000 | USD | 20150209 | Open filing evidence |
| 2014-07-01 – 2014-12-31 | 159419000 | USD | 20150209 | Open filing evidence |
| 2013-10-01 – 2013-12-31 | 70557000 | USD | 20150209 | Open filing evidence |
| 2013-07-01 – 2013-12-31 | 143747000 | USD | 20150209 | Open filing evidence |
Material Reconciling Items · Clinical Controls
Consolidation Items · Statement Business Segments
Source dimensions
us-gaap:ConsolidationItemsAxis=us-gaap:MaterialReconcilingItemsMember;us-gaap:StatementBusinessSegmentsAxis=tech:ClinicalControlsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2014-10-01 – 2014-12-31 | 13698000 | USD | 20150209 | Open filing evidence |
| 2014-07-01 – 2014-12-31 | 27793000 | USD | 20150209 | Open filing evidence |
| 2013-10-01 – 2013-12-31 | 13460000 | USD | 20150209 | Open filing evidence |
| 2013-07-01 – 2013-12-31 | 25938000 | USD | 20150209 | Open filing evidence |
Material Reconciling Items · Protein Platforms
Consolidation Items · Statement Business Segments
Source dimensions
us-gaap:ConsolidationItemsAxis=us-gaap:MaterialReconcilingItemsMember;us-gaap:StatementBusinessSegmentsAxis=tech:ProteinPlatformsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2014-10-01 – 2014-12-31 | 20299000 | USD | 20150209 | Open filing evidence |
| 2014-07-01 – 2014-12-31 | 33213000 | USD | 20150209 | Open filing evidence |
| 2013-10-01 – 2013-12-31 | 0 | USD | 20150209 | Open filing evidence |
| 2013-07-01 – 2013-12-31 | 0 | USD | 20150209 | Open filing evidence |
Operating Segments · Biotechnology
Consolidation Items · Statement Business Segments
Source dimensions
us-gaap:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=tech:BiotechnologyMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2017-10-01 – 2017-12-31 | 101411000 | USD | 20180208 | Open filing evidence |
| 2017-07-01 – 2017-12-31 | 196487000 | USD | 20180208 | Open filing evidence |
| 2017-07-01 – 2017-09-30 | 95076000 | USD | 20171109 | Open filing evidence |
| 2016-07-01 – 2017-06-30 | 364504000 | USD | 20170907 | Open filing evidence |
| 2017-01-01 – 2017-03-31 | 94516000 | USD | 20170510 | Open filing evidence |
| 2016-07-01 – 2017-03-31 | 267256000 | USD | 20170510 | Open filing evidence |
| 2016-10-01 – 2016-12-31 | 85953000 | USD | 20180208 | Open filing evidence |
| 2016-07-01 – 2016-12-31 | 172740000 | USD | 20180208 | Open filing evidence |
| 2016-07-01 – 2016-09-30 | 86787000 | USD | 20171109 | Open filing evidence |
| 2015-07-01 – 2016-06-30 | 317340000 | USD | 20170907 | Open filing evidence |
| 2016-01-01 – 2016-03-31 | 81386000 | USD | 20170510 | Open filing evidence |
| 2015-07-01 – 2016-03-31 | 232984000 | USD | 20170510 | Open filing evidence |
| 2015-10-01 – 2015-12-31 | 75854000 | USD | 20170209 | Open filing evidence |
| 2015-07-01 – 2015-12-31 | 151597000 | USD | 20170209 | Open filing evidence |
| 2015-07-01 – 2015-09-30 | 75743000 | USD | 20161109 | Open filing evidence |
| 2014-07-01 – 2015-06-30 | 308437000 Restated | USD | 20170907 | Open filing evidence |
| 2015-01-01 – 2015-03-31 | 78521000 Restated | USD | 20160510 | Open filing evidence |
| 2014-07-01 – 2015-03-31 | 229347000 Restated | USD | 20160510 | Open filing evidence |
| 2014-10-01 – 2014-12-31 | 74373000 | USD | 20160209 | Open filing evidence |
| 2014-07-01 – 2014-12-31 | 150807000 | USD | 20160209 | Open filing evidence |
| 2014-07-01 – 2014-09-30 | 76453000 Restated | USD | 20151109 | Open filing evidence |
| 2013-07-01 – 2014-06-30 | 285142000 Restated | USD | 20160829 | Open filing evidence |
| 2014-01-01 – 2014-03-31 | 80134000 | USD | 20150511 | Open filing evidence |
| 2013-07-01 – 2014-03-31 | 223882000 Restated | USD | 20150511 | Open filing evidence |
| 2013-07-01 – 2013-09-30 | 73190000 | USD | 20141110 | Open filing evidence |
| 2012-07-01 – 2013-06-30 | 288156000 | USD | 20150831 | Open filing evidence |
| 2013-01-01 – 2013-03-31 | 75285000 | USD | 20140512 | Open filing evidence |
| 2012-07-01 – 2013-03-31 | 214416000 | USD | 20140512 | Open filing evidence |
| 2011-07-01 – 2012-06-30 | 293274000 | USD | 20140829 | Open filing evidence |
| 2010-07-01 – 2011-06-30 | 270287000 | USD | 20130829 | Open filing evidence |
Operating Segments · Clinical Controls
Consolidation Items · Statement Business Segments
Source dimensions
us-gaap:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=tech:ClinicalControlsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2015-07-01 – 2016-06-30 | 104484000 | USD | 20160829 | Open filing evidence |
| 2016-01-01 – 2016-03-31 | 29929000 | USD | 20160510 | Open filing evidence |
| 2015-07-01 – 2016-03-31 | 76013000 | USD | 20160510 | Open filing evidence |
| 2015-10-01 – 2015-12-31 | 25723000 | USD | 20160209 | Open filing evidence |
| 2015-07-01 – 2015-12-31 | 46085000 | USD | 20160209 | Open filing evidence |
| 2015-07-01 – 2015-09-30 | 20362000 | USD | 20151109 | Open filing evidence |
| 2014-07-01 – 2015-06-30 | 77866000 Restated | USD | 20160829 | Open filing evidence |
| 2015-01-01 – 2015-03-31 | 20001000 Restated | USD | 20160510 | Open filing evidence |
| 2014-07-01 – 2015-03-31 | 56417000 Restated | USD | 20160510 | Open filing evidence |
| 2014-10-01 – 2014-12-31 | 17297000 | USD | 20160209 | Open filing evidence |
| 2014-07-01 – 2014-12-31 | 36406000 | USD | 20160209 | Open filing evidence |
| 2014-07-01 – 2014-09-30 | 19119000 Restated | USD | 20151109 | Open filing evidence |
| 2013-07-01 – 2014-06-30 | 72621000 Restated | USD | 20160829 | Open filing evidence |
| 2014-01-01 – 2014-03-31 | 15421000 | USD | 20150511 | Open filing evidence |
| 2013-07-01 – 2014-03-31 | 41358000 Restated | USD | 20150511 | Open filing evidence |
| 2013-07-01 – 2013-09-30 | 12478000 | USD | 20141110 | Open filing evidence |
| 2012-07-01 – 2013-06-30 | 22419000 | USD | 20150831 | Open filing evidence |
| 2013-01-01 – 2013-03-31 | 5707000 | USD | 20140512 | Open filing evidence |
| 2012-07-01 – 2013-03-31 | 16684000 | USD | 20140512 | Open filing evidence |
| 2011-07-01 – 2012-06-30 | 21286000 | USD | 20140829 | Open filing evidence |
| 2010-07-01 – 2011-06-30 | 19675000 | USD | 20130829 | Open filing evidence |
Operating Segments · Diagnostics
Consolidation Items · Statement Business Segments
Source dimensions
us-gaap:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=tech:DiagnosticsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2017-10-01 – 2017-12-31 | 23429000 | USD | 20180208 | Open filing evidence |
| 2017-07-01 – 2017-12-31 | 48415000 | USD | 20180208 | Open filing evidence |
| 2017-07-01 – 2017-09-30 | 24986000 | USD | 20171109 | Open filing evidence |
| 2016-07-01 – 2017-06-30 | 107139000 | USD | 20170907 | Open filing evidence |
| 2017-01-01 – 2017-03-31 | 25978000 | USD | 20170510 | Open filing evidence |
| 2016-07-01 – 2017-03-31 | 74542000 | USD | 20170510 | Open filing evidence |
| 2016-10-01 – 2016-12-31 | 24330000 | USD | 20180208 | Open filing evidence |
| 2016-07-01 – 2016-12-31 | 48563000 | USD | 20180208 | Open filing evidence |
| 2016-07-01 – 2016-09-30 | 24233000 | USD | 20171109 | Open filing evidence |
| 2015-07-01 – 2016-06-30 | 104484000 | USD | 20170907 | Open filing evidence |
| 2016-01-01 – 2016-03-31 | 29929000 | USD | 20170510 | Open filing evidence |
| 2015-07-01 – 2016-03-31 | 76013000 | USD | 20170510 | Open filing evidence |
| 2015-10-01 – 2015-12-31 | 25723000 | USD | 20170209 | Open filing evidence |
| 2015-07-01 – 2015-12-31 | 46085000 | USD | 20170209 | Open filing evidence |
| 2015-07-01 – 2015-09-30 | 20362000 | USD | 20161109 | Open filing evidence |
| 2014-07-01 – 2015-06-30 | 77866000 | USD | 20170907 | Open filing evidence |
Operating Segments · Protein Platforms
Consolidation Items · Statement Business Segments
Source dimensions
us-gaap:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=tech:ProteinPlatformsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2017-10-01 – 2017-12-31 | 29388000 | USD | 20180208 | Open filing evidence |
| 2017-07-01 – 2017-12-31 | 54028000 | USD | 20180208 | Open filing evidence |
| 2017-07-01 – 2017-09-30 | 24640000 | USD | 20171109 | Open filing evidence |
| 2016-07-01 – 2017-06-30 | 91464000 | USD | 20170907 | Open filing evidence |
| 2017-01-01 – 2017-03-31 | 23586000 | USD | 20170510 | Open filing evidence |
| 2016-07-01 – 2017-03-31 | 64707000 | USD | 20170510 | Open filing evidence |
| 2016-10-01 – 2016-12-31 | 21548000 | USD | 20180208 | Open filing evidence |
| 2016-07-01 – 2016-12-31 | 41121000 | USD | 20180208 | Open filing evidence |
| 2016-07-01 – 2016-09-30 | 19573000 | USD | 20171109 | Open filing evidence |
| 2015-07-01 – 2016-06-30 | 77324000 | USD | 20170907 | Open filing evidence |
| 2016-01-01 – 2016-03-31 | 19693000 | USD | 20170510 | Open filing evidence |
| 2015-07-01 – 2016-03-31 | 55327000 | USD | 20170510 | Open filing evidence |
| 2015-10-01 – 2015-12-31 | 19337000 | USD | 20170209 | Open filing evidence |
| 2015-07-01 – 2015-12-31 | 35634000 | USD | 20170209 | Open filing evidence |
| 2015-07-01 – 2015-09-30 | 16296000 | USD | 20161109 | Open filing evidence |
| 2014-07-01 – 2015-06-30 | 66249000 Restated | USD | 20170907 | Open filing evidence |
| 2015-01-01 – 2015-03-31 | 15669000 | USD | 20160510 | Open filing evidence |
| 2014-07-01 – 2015-03-31 | 49061000 | USD | 20160510 | Open filing evidence |
| 2014-10-01 – 2014-12-31 | 20478000 | USD | 20160209 | Open filing evidence |
| 2014-07-01 – 2014-12-31 | 33382000 | USD | 20160209 | Open filing evidence |
| 2014-07-01 – 2014-09-30 | 12914000 | USD | 20151109 | Open filing evidence |
| 2013-07-01 – 2014-06-30 | 0 | USD | 20160829 | Open filing evidence |
| 2013-07-01 – 2013-09-30 | 0 | USD | 20141110 | Open filing evidence |
| 2012-07-01 – 2013-06-30 | 0 | USD | 20150831 | Open filing evidence |
CN
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=country:CN| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2011-07-01 – 2012-06-30 | 11378000 | USD | 20120829 | Open filing evidence |
| 2010-07-01 – 2011-06-30 | 8299000 | USD | 20120829 | Open filing evidence |
| 2009-07-01 – 2010-06-30 | 6792000 | USD | 20120829 | Open filing evidence |
US
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=country:US| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2011-07-01 – 2012-06-30 | 172310000 | USD | 20120829 | Open filing evidence |
| 2010-07-01 – 2011-06-30 | 159857000 | USD | 20120829 | Open filing evidence |
| 2009-07-01 – 2010-06-30 | 148137000 | USD | 20120829 | Open filing evidence |
Biotechnology
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=tech:BiotechnologyMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2013-01-01 – 2013-03-31 | 75285000 | USD | 20130510 | Open filing evidence |
| 2012-07-01 – 2013-03-31 | 214416000 | USD | 20130510 | Open filing evidence |
| 2012-10-01 – 2012-12-31 | 69628000 | USD | 20130211 | Open filing evidence |
| 2012-07-01 – 2012-12-31 | 139131000 | USD | 20130211 | Open filing evidence |
| 2012-07-01 – 2012-09-30 | 69503000 | USD | 20121109 | Open filing evidence |
| 2011-07-01 – 2012-06-30 | 293274000 | USD | 20120829 | Open filing evidence |
| 2012-01-01 – 2012-03-31 | 78180000 | USD | 20130510 | Open filing evidence |
| 2011-07-01 – 2012-03-31 | 220291000 | USD | 20130510 | Open filing evidence |
| 2011-10-01 – 2011-12-31 | 69808000 | USD | 20130211 | Open filing evidence |
| 2011-07-01 – 2011-12-31 | 142111000 | USD | 20130211 | Open filing evidence |
| 2011-07-01 – 2011-09-30 | 72303000 | USD | 20121109 | Open filing evidence |
| 2010-07-01 – 2011-06-30 | 270287000 | USD | 20120829 | Open filing evidence |
| 2011-01-01 – 2011-03-31 | 71120000 | USD | 20120510 | Open filing evidence |
| 2010-07-01 – 2011-03-31 | 197241000 | USD | 20120510 | Open filing evidence |
| 2010-10-01 – 2010-12-31 | 63080000 | USD | 20120207 | Open filing evidence |
| 2010-07-01 – 2010-12-31 | 126121000 | USD | 20120207 | Open filing evidence |
| 2010-07-01 – 2010-09-30 | 63041000 | USD | 20111109 | Open filing evidence |
| 2009-07-01 – 2010-06-30 | 250653000 | USD | 20120829 | Open filing evidence |
| 2008-07-01 – 2009-06-30 | 246454000 | USD | 20110829 | Open filing evidence |
Europe
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=tech:EuropeMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2011-07-01 – 2012-06-30 | 90142000 | USD | 20120829 | Open filing evidence |
| 2010-07-01 – 2011-06-30 | 83676000 | USD | 20120829 | Open filing evidence |
| 2009-07-01 – 2010-06-30 | 78496000 | USD | 20120829 | Open filing evidence |
Hematology
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=tech:HematologyMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2013-01-01 – 2013-03-31 | 5707000 | USD | 20130510 | Open filing evidence |
| 2012-07-01 – 2013-03-31 | 16684000 | USD | 20130510 | Open filing evidence |
| 2012-10-01 – 2012-12-31 | 5455000 | USD | 20130211 | Open filing evidence |
| 2012-07-01 – 2012-12-31 | 10977000 | USD | 20130211 | Open filing evidence |
| 2012-07-01 – 2012-09-30 | 5522000 | USD | 20121109 | Open filing evidence |
| 2011-07-01 – 2012-06-30 | 21286000 | USD | 20120829 | Open filing evidence |
| 2012-01-01 – 2012-03-31 | 5441000 | USD | 20130510 | Open filing evidence |
| 2011-07-01 – 2012-03-31 | 15588000 | USD | 20130510 | Open filing evidence |
| 2011-10-01 – 2011-12-31 | 4854000 | USD | 20130211 | Open filing evidence |
| 2011-07-01 – 2011-12-31 | 10147000 | USD | 20130211 | Open filing evidence |
| 2011-07-01 – 2011-09-30 | 5293000 | USD | 20121109 | Open filing evidence |
| 2010-07-01 – 2011-06-30 | 19675000 | USD | 20120829 | Open filing evidence |
| 2011-01-01 – 2011-03-31 | 5151000 | USD | 20120510 | Open filing evidence |
| 2010-07-01 – 2011-03-31 | 14683000 | USD | 20120510 | Open filing evidence |
| 2010-10-01 – 2010-12-31 | 4628000 | USD | 20120207 | Open filing evidence |
| 2010-07-01 – 2010-12-31 | 9532000 | USD | 20120207 | Open filing evidence |
| 2010-07-01 – 2010-09-30 | 4904000 | USD | 20111109 | Open filing evidence |
| 2009-07-01 – 2010-06-30 | 18394000 | USD | 20120829 | Open filing evidence |
| 2008-07-01 – 2009-06-30 | 17502000 | USD | 20110829 | Open filing evidence |
Other Asia
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=tech:OtherAsiaMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2011-07-01 – 2012-06-30 | 25988000 | USD | 20120829 | Open filing evidence |
| 2010-07-01 – 2011-06-30 | 24715000 | USD | 20120829 | Open filing evidence |
| 2009-07-01 – 2010-06-30 | 22372000 | USD | 20120829 | Open filing evidence |
Other Revenues From Business Held For Sale
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=tech:OtherRevenuesFromBusinessHeldForSaleMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-07-01 – 2025-03-31 | 4152000 | USD | 20250508 | Open filing evidence |
| 2024-10-01 – 2024-12-31 | 1849000 | USD | 20250206 | Open filing evidence |
| 2024-07-01 – 2024-12-31 | 4152000 | USD | 20250206 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 2303000 | USD | 20241105 | Open filing evidence |
| 2023-07-01 – 2024-06-30 | 4153000 | USD | 20240822 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 2093000 | USD | 20250508 | Open filing evidence |
| 2023-07-01 – 2024-03-31 | 2093000 | USD | 20250508 | Open filing evidence |
Rest Of World
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=tech:RestOfWorldMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2011-07-01 – 2012-06-30 | 14742000 | USD | 20120829 | Open filing evidence |
| 2010-07-01 – 2011-06-30 | 13415000 | USD | 20120829 | Open filing evidence |
| 2009-07-01 – 2010-06-30 | 13250000 | USD | 20120829 | Open filing evidence |